ReviewThe Lancet regional health. Europe2025

A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis.

Jeffrey V Lazarus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.